ChestSight™
AI powered X-Ray Chest Cancer Screening Solution
Overview
ChestSight™ AI module is designed to automatically analyze chest radiography and detect a wide range of thoracic abnormalities with high accuracy and speed. Leveraging advanced deep learning algorithms trained on millions of validated images, the system assists radiologists and clinicians in identifying pathology such as pneumonia, tuberculosis, lung nodules, plural effusion, cardiomegaly, and pneumothorax.
The AI software is an innovative solution for mass screening and early detection of lung diseases making it ideal for public health programs and remote healthcare settings. The platform supports both cloud-based and on-premises deployment, ensuring accessibility in resource-limited environments while maintaining data security and compliance with healthcare standards.
Key Features
- Multi-pathology detection with probability scoring and visual heatmaps for explainability.
- Triage & prioritization of urgent cases (e.g., pneumothorax) to reduce report turnaround time.
- Integration with PACS/VNA for seamless workflow adoption without disrupting existing systems.
- Screening program support for public health initiatives, especially for TB and lung cancer early detection.
- Quantitative analysis for disease monitoring, progression tracking, and treatment response assessment.
Key Benefits
- The ramyro Xray Chest AI solution improves early lung tumor detection with rib suppression and quality enhancement, integrates quickly into workflows, is cost-effective for low-resource settings, and boosts treatment outcomes through earlier diagnosis.
- By enhancing diagnostic confidence, improving workflow efficiency, and enabling earlier detection, the X-ray Chest AI module empowers healthcare providers to deliver faster, more accurate, and more accessible thoracic imaging services whether in hospitals, clinics, or teleradiology networks.